BioXcel Therapeutics Files Clinical Trial Application for the Development of BXCL701 and Pembrolizumab in Neuroendocrine Prostate ...
Expands global footprint for lead immuno-oncology program, BXCL701 Patient recruitment in US tNEPC study on-track; additional sites being activated Immuno-oncology Clinical Advisory Board expanded with addition of prominent U.K. medical oncologist, …